The US Food and Drug Administration (FDA) has selected seven companies to participate in its new PreCheck Pilot Program, an initiative intended to expand domestic pharmaceutical manufacturing capacity and reinforce the resilience of the nation’s drug supply chain.
The program is designed to give manufacturers earlier and more predictable